Format
Sort by
Items per page

Send to

Choose Destination

Best matches for anticholinergic drugs dementia:

Search results

Items: 1 to 20 of 1354

1.

Sex Differences in the Prevalent Use of Oral Formulations of Cholinesterase Inhibitors in Older Adults with Dementia.

Zhu L, Rochon PA, Gruneir A, Wu W, Giannakeas V, Austin PC, Stall NM, McCarthy L, Alberga A, Herrmann N, Gill SS, Bronskill SE.

Drugs Aging. 2019 Jul 15. doi: 10.1007/s40266-019-00690-9. [Epub ahead of print]

PMID:
31309528
2.

Association of Benzodiazepine and Anticholinergic Drug Usage With Incident Dementia: A Prospective Cohort Study of Community-Dwelling Older Adults.

Hafdi M, Hoevenaar-Blom MP, Beishuizen CRL, Moll van Charante EP, Richard E, van Gool WA.

J Am Med Dir Assoc. 2019 Jul 9. pii: S1525-8610(19)30428-1. doi: 10.1016/j.jamda.2019.05.010. [Epub ahead of print]

PMID:
31300339
3.

Association between Anticholinergic Medication Use and Risk of Dementia among Patients with Parkinson's Disease.

Sheu JJ, Tsai MT, Erickson SR, Wu CH.

Pharmacotherapy. 2019 Jun 28. doi: 10.1002/phar.2305. [Epub ahead of print]

PMID:
31251824
4.

Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study.

Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J.

JAMA Intern Med. 2019 Jun 24. doi: 10.1001/jamainternmed.2019.0677. [Epub ahead of print]

5.

Anticholinergic burden and risk of cognitive impairment in elderly nursing home residents with depression.

Chatterjee S, Bali V, Carnahan RM, Chen H, Johnson ML, Aparasu RR.

Res Social Adm Pharm. 2019 May 28. pii: S1551-7411(18)30971-9. doi: 10.1016/j.sapharm.2019.05.020. [Epub ahead of print]

PMID:
31182419
6.

Lewy body dementia: therapeutic propositions according to evidence based medicine and practice.

Verny M, Blanc F.

Geriatr Psychol Neuropsychiatr Vieil. 2019 Jun 1;17(2):189-197. doi: 10.1684/pnv.2019.0803.

PMID:
31162119
7.

Interaction of synthesized nitrogen enriched graphene quantum dots with novel anti-Alzheimer's drugs: spectroscopic insights.

Sharma S, Singh N, Nepovimova E, Korabecny J, Kuca K, Satnami ML, Ghosh KK.

J Biomol Struct Dyn. 2019 May 27:1-16. doi: 10.1080/07391102.2019.1619625. [Epub ahead of print]

PMID:
31096863
8.

Real-Life Data on Mirabegron in Neurogenic Bladder Dysfunction.

Soebadi MA, Hakim L, Van der Aa F, De Ridder D.

Urol Int. 2019 May 16:1-7. doi: 10.1159/000500349. [Epub ahead of print]

PMID:
31096260
9.

Use of Anticholinergic Drugs According to Various Criteria and Their Association With Psychological Well-Being and Mortality in Long-Term Care Facilities.

Aalto UL, Finne-Soveri H, Kautiainen H, Roitto HM, Öhman H, Pitkälä KH.

J Am Med Dir Assoc. 2019 Mar 22. pii: S1525-8610(19)30233-6. doi: 10.1016/j.jamda.2019.02.007. [Epub ahead of print]

PMID:
30910551
10.

Polypharmacy in an Elderly Population: Enhancing Medication Management Through the Use of Clinical Decision Support Software Platforms.

Keine D, Zelek M, Walker JQ, Sabbagh MN.

Neurol Ther. 2019 Jun;8(1):79-94. doi: 10.1007/s40120-019-0131-6. Epub 2019 Mar 21.

11.

Synthesis and AChE-Inhibitory Activity of New Benzimidazole Derivatives.

Acar Cevik U, Saglik BN, Levent S, Osmaniye D, Kaya Cavuşoglu B, Ozkay Y, Kaplancikli ZA.

Molecules. 2019 Feb 28;24(5). pii: E861. doi: 10.3390/molecules24050861.

12.

Molecular Docking Studies of Coumarins Isolated from Extracts and Essential Oils of Zosima absinthifolia Link as Potential Inhibitors for Alzheimer's Disease.

Karakaya S, Koca M, Yılmaz SV, Yıldırım K, Pınar NM, Demirci B, Brestic M, Sytar O.

Molecules. 2019 Feb 17;24(4). pii: E722. doi: 10.3390/molecules24040722.

13.

Tacrines for Alzheimer's disease therapy. III. The PyridoTacrines.

de Los Ríos C, Marco-Contelles J.

Eur J Med Chem. 2019 Mar 15;166:381-389. doi: 10.1016/j.ejmech.2019.02.005. Epub 2019 Feb 4. Review.

PMID:
30739821
14.

Constipation and laxative use among people living in nursing homes in 2007 and 2013.

Gustafsson M, Lämås K, Isaksson U, Sandman PO, Lövheim H.

BMC Geriatr. 2019 Feb 8;19(1):38. doi: 10.1186/s12877-019-1054-x.

15.

Antimuscarinic drug therapy for overactive bladder syndrome in the elderly - are the concerns justified?

Khastgir J.

Expert Opin Pharmacother. 2019 May;20(7):813-820. doi: 10.1080/14656566.2019.1574749. Epub 2019 Feb 6. Review.

PMID:
30724647
16.

The effects of pinoresinol on cholinergic dysfunction-induced memory impairments and synaptic plasticity in mice.

Yu J, Kwon H, Cho E, Jeon J, Kang RH, Youn K, Jun M, Lee YC, Ryu JH, Kim DH.

Food Chem Toxicol. 2019 Mar;125:376-382. doi: 10.1016/j.fct.2019.01.017. Epub 2019 Jan 24.

PMID:
30685474
17.
18.
19.

Drugs for dementia: exercise is medicine.

Bailey DM, Calverley TA, Corkill R.

BMJ. 2019 Jan 10;364:k5438. doi: 10.1136/bmj.k5438. No abstract available.

PMID:
30630812
20.

Evaluation of the protective effect of Myrtus communis in scopolamine-induced Alzheimer model through cholinergic receptors.

Aykac A, Ozbeyli D, Uncu M, Ertaş B, Kılınc O, Şen A, Orun O, Sener G.

Gene. 2019 Mar 20;689:194-201. doi: 10.1016/j.gene.2018.12.007. Epub 2018 Dec 13.

PMID:
30553998

Supplemental Content

Loading ...
Support Center